Copyright Reports & Markets. All rights reserved.

Global Cancer Treatment Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Cancer Treatment Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Chemotherapy
      • 1.2.2 Targeted Therapy
      • 1.2.3 Immunotherapy
      • 1.2.4 Hormonal Therapy (Biologic Therapy)
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Blood Cancer
      • 1.3.2 Breast Cancer
      • 1.3.3 Gastrointestinal Cancer
      • 1.3.4 Prostate Cancer
      • 1.3.5 Respiratory/Lung Cancer
      • 1.3.6 Other Cancers
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Cancer Treatment Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis
      • 2.2.1 Business Overview
      • 2.2.2 Cancer Treatment Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Celgene
      • 2.3.1 Business Overview
      • 2.3.2 Cancer Treatment Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Bristol-Myers Squibb
      • 2.4.1 Business Overview
      • 2.4.2 Cancer Treatment Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Amgen
      • 2.5.1 Business Overview
      • 2.5.2 Cancer Treatment Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Johnson & Johnson
      • 2.6.1 Business Overview
      • 2.6.2 Cancer Treatment Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Cancer Treatment Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Takeda
      • 2.8.1 Business Overview
      • 2.8.2 Cancer Treatment Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Eli Lilly
      • 2.9.1 Business Overview
      • 2.9.2 Cancer Treatment Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 AstraZeneca
      • 2.10.1 Business Overview
      • 2.10.2 Cancer Treatment Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Astellas
      • 2.11.1 Business Overview
      • 2.11.2 Cancer Treatment Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Merck & Co.
      • 2.12.1 Business Overview
      • 2.12.2 Cancer Treatment Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Sanofi
      • 2.13.1 Business Overview
      • 2.13.2 Cancer Treatment Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Bayer
      • 2.14.1 Business Overview
      • 2.14.2 Cancer Treatment Drugs Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Biogen Idec
      • 2.15.1 Business Overview
      • 2.15.2 Cancer Treatment Drugs Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Eisai
      • 2.16.1 Business Overview
      • 2.16.2 Cancer Treatment Drugs Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Teva
      • 2.17.1 Business Overview
      • 2.17.2 Cancer Treatment Drugs Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Otsuka
      • 2.18.1 Business Overview
      • 2.18.2 Cancer Treatment Drugs Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Merck KGaA
      • 2.19.1 Business Overview
      • 2.19.2 Cancer Treatment Drugs Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Ipsen
      • 2.20.1 Business Overview
      • 2.20.2 Cancer Treatment Drugs Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 AbbVie
      • 2.21.1 Business Overview
      • 2.2.2 Cancer Treatment Drugs Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Gilead Sciences
      • 2.22.1 Business Overview
      • 2.22.2 Cancer Treatment Drugs Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Cancer Treatment Drugs Market Analysis by Regions

    • 4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Cancer Treatment Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    5 North America Cancer Treatment Drugs by Country

    • 5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    6 Europe Cancer Treatment Drugs by Country

    • 6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Cancer Treatment Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Cancer Treatment Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Cancer Treatment Drugs by Country

    • 7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    8 South America Cancer Treatment Drugs by Country

    • 8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Cancer Treatment Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Cancer Treatment Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Cancer Treatment Drugs by Countries

    • 9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Cancer Treatment Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Cancer Treatment Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Cancer Treatment Drugs Sales and Growth Rate (2014-2019)

    10 Global Cancer Treatment Drugs Market Segment by Type

    • 10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Chemotherapy Sales Growth and Price
      • 10.2.1 Global Chemotherapy Sales Growth (2014-2019)
      • 10.2.2 Global Chemotherapy Price (2014-2019)
    • 10.3 Targeted Therapy Sales Growth and Price
      • 10.3.1 Global Targeted Therapy Sales Growth (2014-2019)
      • 10.3.2 Global Targeted Therapy Price (2014-2019)
    • 10.4 Immunotherapy Sales Growth and Price
      • 10.4.1 Global Immunotherapy Sales Growth (2014-2019)
      • 10.4.2 Global Immunotherapy Price (2014-2019)
    • 10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
      • 10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2014-2019)
      • 10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Cancer Treatment Drugs Market Segment by Application

    • 11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Blood Cancer Sales Growth (2014-2019)
    • 11.3 Breast Cancer Sales Growth (2014-2019)
    • 11.4 Gastrointestinal Cancer Sales Growth (2014-2019)
    • 11.5 Prostate Cancer Sales Growth (2014-2019)
    • 11.6 Respiratory/Lung Cancer Sales Growth (2014-2019)
    • 11.7 Other Cancers Sales Growth (2014-2019)

    12 Cancer Treatment Drugs Market Forecast (2019-2024)

    • 12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Cancer Treatment Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Cancer Treatment Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Cancer Treatment Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Cancer Treatment Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2019-2024)
    • 12.3 Cancer Treatment Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Cancer Treatment Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Cancer Treatment Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Cancer Treatment Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Cancer Treatment Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

      Scope of the Report:
      The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
      Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
      Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
      North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
      The worldwide market for Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Roche
      Novartis
      Celgene
      Bristol-Myers Squibb
      Amgen
      Johnson & Johnson
      Pfizer
      Takeda
      Eli Lilly
      AstraZeneca
      Astellas
      Merck & Co.
      Sanofi
      Bayer
      Biogen Idec
      Eisai
      Teva
      Otsuka
      Merck KGaA
      Ipsen
      AbbVie
      Gilead Sciences

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Chemotherapy
      Targeted Therapy
      Immunotherapy
      Hormonal Therapy (Biologic Therapy)
      Others

      Market Segment by Applications, can be divided into
      Blood Cancer
      Breast Cancer
      Gastrointestinal Cancer
      Prostate Cancer
      Respiratory/Lung Cancer
      Other Cancers

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Cancer Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Cancer Treatment Drugs, with price, sales, revenue and global market share of Cancer Treatment Drugs in 2017 and 2018.
      Chapter 3, the Cancer Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now